Positive news for new Cushing’s drug

September 23, 2019

In a press release, Strongbridge Biopharma announced comprehensive positive results of their Phase 3 SONICS study of RECORLEVTM (levoketoconazole) for the potential treatment of endogenous Cushing’s syndrome. The results were published online in The Lancet

A review of drugs for tumors that produce ACTH

July 16, 2019

In this podcast, Dr. Blevins reviews a study conducted at the Ludwig Maximilian University of Munich, Germany on pituitary tumor therapeutics and the treatment for tumors that produce ACTH and cause Cushing’s.  Dr. Blevins reviews

The incidence of Cushing’s

June 3, 2019

In this podcast, we discuss the latest data on the incidence of Cushing’s disease worldwide based on a recent Swedish study on the subject, and the importance of disease awareness in early diagnosis.